Bioretec Oy

Equities

BRETEC

FI4000480454

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Helsinki Other stock markets 17:00:00 14/06/2024 BST			5-day change	1st Jan Change
2.79 ^EUR	-0.36%		+1.09%	+16.25%

05-21	Medical Device Company Bioretec Names New CEO	MT
05-20	Bioretec Ltd. Announces Transfer of Timo Lehtonen from CEO to Chief Technology Officer	CI

Bioretec Ltd. Announces Transfer of Timo Lehtonen from CEO to Chief Technology Officer

May 20, 2024 at 04:00 pm

Bioretec Ltd. announced that Timo Lehtonen, Bioretec's CEO since 2019, will transfer to the position of Chief Technology Officer (CTO) and continue to lead the development of Bioretec's future product pipeline.

Latest news about Bioretec Oy

Medical Device Company Bioretec Names New CEO	05-21	MT
Bioretec Ltd. Announces Transfer of Timo Lehtonen from CEO to Chief Technology Officer	05-20	CI
Bioretec Ltd Announces CEO Changes	05-20	CI
Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	04-05	CI
Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	03-22	MT
Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition	03-21	CI
Bioretec Secures US FDA Breakthrough Device Designation for Spinal Interbody Cage Implant	03-14	MT
Bioretec Has Been Granted FDA Breakthrough Device Designation Status for its RemeOs Spinal Interbody Cage	03-14	CI
Bioretec Expects EU Regulatory Approval for Trauma Screw in Q2	03-11	MT
Bioretec's European Market Authorization for RemeOs Trauma Screw Proceeded to Expert Panel Evaluation	03-08	CI
Bioretec to Initiate Search for New CEO	11-16	MT
Bioretec Ltd Announces CEO Changes	11-16	CI
Bioretec Estimates the Approval of the European Market Authorization for the Biodegradable RemeOs? Trauma Screw Will Move to the First Quarter of 2024	18/10/23	CI
Bioretec Secures Distribution Agreement for Trauma Screws in US Market	12/09/23	MT
Bioretec Signs Distribution Deal for Launch of Orthopedic Product in US	12/09/23	MT
Bioretec Ltd. Enters into the U.S. Distribution Agreement with Spartan Medical Inc. for the RemeOs Screws	12/09/23	CI
Bioretec Wins R&D Grant from Business Finland for Developing Advanced Biodegradable Implants	06/09/23	MT
Bioretec Ltd Unveils Its Revitalized Scientific Advisory Board	16/08/23	CI
Bioretec Oy Appoints Esa Hallinen as Director of Operations and Member of the Management Team	14/07/23	CI
Bioretec Ltd Acquires New CNC Machining Center to Increase Production Capacity of RemeOs Products at its Factory in Tampere, Finland	13/06/23	CI
Bioretec Oy Approves Management Appointments	26/05/23	CI
Bioretec Ltd Appoints Dr. Jeremy Dublon as Regulatory Advisor	16/05/23	CI
Bioretec Ltd, Receives U.S. Market Authorization for Its RemeOs Trauma Screw from the U.S. Food and Drug Administration	24/04/23	CI
Bioretec Wins US FDA Nod for Bioresorbable Orthopedic Implant	30/03/23	MT
Bioretec Ltd Receives Market Authorization of the U.S. Food and Drug Administration for Its Pioneering Remeos Traversed with the Clinical Trial	30/03/23	CI

Chart Bioretec Oy

Duration

Period

More charts

Company Profile

Bioretec Oy is a Finland-based medical device manufacturer company focusing on the development of strong, safe and reliable bioresorbable implants for pediatric and adult orthopedics. The Company operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oyâs existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Companyâs products are used all over the world.

Sector

Medical Equipment, Supplies & Distribution

Calendar

14/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Bioretec Oy

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.79 EUR

Average target price

3.85 EUR

Spread / Average Target

+37.99%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
BIORETEC OY	+16.25%	60.69M
SHOCKWAVE MEDICAL	+75.67%	12.57B
PENUMBRA, INC.	-25.35%	7.28B
MASIMO CORPORATION	+15.77%	7.2B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+14.52%	5.47B
GETINGE AB	-18.50%	4.73B
APT MEDICAL INC.	+14.91%	4.09B
ASAHI INTECC CO., LTD.	-23.67%	3.78B
INARI MEDICAL, INC.	-30.22%	2.63B
NOVOCURE LIMITED	+42.93%	2.3B

Medical Equipment